-
Mashup Score: 16Cancerwise Podcast - 19 hour(s) ago
MD Anderson’s Cancerwise podcast features insights from our experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories from survivors and caregivers who’ve faced cancer firsthand.
Source: www.mdanderson.orgCategories: General Medicine NewsTweet
-
Mashup Score: 93
Immunotherapy is used to treat many types of cancer, and the list is growing. But immunotherapy doesn’t work for all cancers or patients yet. Here’s which patients and cancers may qualify for immunotherapy.
Source: www.mdanderson.orgCategories: General Medicine News, Onc News and JournalsTweet-
Thanks to clinical trials, a growing number of cancers can be treated with immunotherapy. Here's a list: https://t.co/4y71ZlTTKk @ANaingMD @DrSapnaPatel #immunotherapy #EndCancer
-
-
Mashup Score: 28Targeting brain-liver pathway with electronic wearables could prevent cancer-associated weight and muscle loss - 7 day(s) ago
Targeting brain-liver pathway with electronic wearables could prevent cancer-associated weight and muscle loss
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
Findings from MD Anderson researchers suggest that targeting an neuroinflammatory pathway by non-invasive, electronic wearables could potentially delay or slow cancer-associated cachexia: https://t.co/J4z0oz0nlW #EndCancer
-
-
Mashup Score: 0Beauty products and cancer: Are you at risk? - 7 day(s) ago
From carcinogens to endocrine-disrupting chemicals, could the products you use to keep clean and feel your best harm your health? Lorenzo Cohen, Ph.D., director of MD Anderson’s Integrative Medicine Program, shares tips for choosing personal care products while managing your cancer risk.
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
Research shows that the more you can clean up your personal environment, the lower your risk of cancer. @MDAndersonNews #AnticancerLiving https://t.co/oyzocHfP3A
-
-
Mashup Score: 24Novel drug confirms NSD2 protein as therapeutic target in lung and pancreatic cancers - 8 day(s) ago
Novel drug confirms NSD2 protein as therapeutic target in lung and pancreatic cancers
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
Studies have shown that the NSD2 protein fuels cancer growth, particularly in difficult-to-treat cancers with KRAS mutations. A new multi-institutional study confirmed that NSD2 can be targeted with a new drug. Learn more: https://t.co/syd56z167s #EndCancer
-
-
Mashup Score: 16
MDS subtype associated with poor outcomes after venetoclax-based therapy
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
Recent research findings suggest that monitoring bone marrow erythroid cells can benefit patients with myelodysplastic syndromes. Learn more: https://t.co/3LKM5KUHTk #EndCancer
-
-
Mashup Score: 41Blood Donations - 9 day(s) ago
Locations are available throughout the Houston area. You can also call us at 713-792-7777. Blood donations take 30-45 minutes and can be done every eight weeks. Platelet donations take 70-90 minutes and donors can give every seven days. Now, as always, it is safe to donate blood. All donations are made by appointment at the MD Anderson Blood Donor Center on Holly Hall Street in the Texas Medical Center. Donors must be 17 years or older. All blood donated to the MD Anderson Blood Bank is used to treat MD
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
✅Another #platelet donation today. I love how @MDAndersonNews allows you to donate to honor specific patients. If they don't need🩸, they get an honorarium credited to their account. Donations are always needed; they're a lifesaver. Literally. https://t.co/cUrYm6GR78 https://t.co/7MSzplCOvs
-
-
Mashup Score: 25New biomarker and strategy identify and overcome resistance in HR+/HER2- breast cancer - 10 day(s) ago
New biomarker and strategy identify and overcome resistance in HR+/HER2- breast cancer
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
MD Anderson researchers discovered that the protein IL-6 becomes elevated in patients with hormone receptor-positive HER2-negative metastatic breast cancer who stopped responding to CDK4/6 inhibitors. How physicians may use this data: https://t.co/xLsfef5SCC #EndCancer
-
-
Mashup Score: 26
Study provides insights into advanced ovarian cancer tumors after treatment
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
MD Anderson researchers used spatial multi-omics to characterize minimal residual disease lesions in patients with advanced ovarian cancer, providing insights into potential targets to guide personalized treatments. Learn more: https://t.co/Ke0VZwKmkB #EndCancer
-
-
Mashup Score: 17Lorazepam significantly reduces agitation in patients with advanced cancer and delirium - 15 day(s) ago
Lorazepam significantly reduces agitation in patients with advanced cancer and delirium
Source: www.mdanderson.orgCategories: General Medicine NewsTweet-
Follow-up results from a 2024 Phase II study show that lorazepam, alone or with haloperidol, significantly reduced agitation more than haloperidol alone or a placebo. What these findings suggest for managing agitation in patients with advanced cancer: https://t.co/aRtodAkLGZ
-
Do people undergoing cancer treatment benefit from taking vitamins and supplements? Our experts weigh in and share the risks in the latest episode of the Cancerwise podcast. Listen here or wherever you get your podcasts: https://t.co/lQo5WDJlCA https://t.co/jmsi6NJTiC